Search Results for “EC” – Page 585 – media

Seasonal flu kills up to 650,000 worldwide every year, study shows

Seasonal flu kills between 291,000 and 646,000 people worldwide every year, a new analysis of data from 47 countries suggested Wednesday.
- Source: news.mb
- 408
- December 26, 2017
Researches Seasonal flu
Health System CIOs Are Ready to Take mHealth to the Next Level

With some three-quarters of the nation’s health systems now having an mHealth communications strategy, CIOs are now setting their sights on integrating those platforms with clinical decision support tools, including the EHR.
- Source: mhealthintelligence
- 669
- December 25, 2017
CIO mHealth Researches
Clinicians still struggle to quickly access EHRs at point of care

Computers and workstations on wheels (WoWs) were designed to help clinicians spend less time working from nursing-station desktops and more time at the point of care. The reality, however, is that the ideal has yet to be fully realized. All too often care team workflows remain fragmented because of the need to access patient data and clinical information from multiple disparate systems.
- Source: healthcareitnews
- 468
- December 25, 2017
Clinical EHR Researches WoWs
What to know about allergy shots

Allergy shots are how allergen immunotherapy is commonly administered. This method is a proven way of treating reactions to allergens.
- Source: medicalnewstoday
- 543
- December 25, 2017
Allergy immunotherapy
Roche and Ignyta Reach Definitive Merger Agreement

Roche (SIX: RO, ROG; OTCQX: RHHBY) and Ignyta, Inc. (NASDAQ: RXDX) today announced they have entered into a definitive merger agreement for Roche to fully acquire Ignyta at a price of US$ 27.00 per share in an all-cash transaction. This corresponds to a total transaction value of US$ 1.7 billion on a fully diluted basis. This price represents a premium of 74% to Ignyta’s closing price on 21 December 2017 and a premium of 71% and 89% to Ignyta’s 30-day and 90-day volume weighted average share price on 21 December 2017, respectively. The merger agreement has been unanimously approved by the boards of Ignyta and Roche.
- Source: Roche
- 524
- December 25, 2017
Ignyta Market Views Roche
U.S. FDA Grants Priority Review to Janssen for Apalutamide as a Treatment for Non-Metastatic Castration-Resistant Prostate Cancer

Janssen Biotech, Inc. (Janssen) announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review designation for the New Drug Application (NDA) for apalutamide, an investigational, next-generation oral androgen receptor (AR) inhibitor for the treatment of men with non-metastatic castration-resistant prostate cancer (CRPC). Currently, there are no FDA-approved treatments for patients with non-metastatic CRPC.
- Source: Janssen
- 484
- December 25, 2017
CRPC inhibitor New Approvals
3 Amazing Advances in Pharmaceutical Drugs in 2017

As 2017 draws to a close, we look back at a year where advances in pharmaceutical drug therapies brought new hope to people from across the globe. These steps forward bring with them a sense of suspense as we wait for more ground-breaking work to be accomplished in 2018. Here is Drugdu.com’s list of medical advances that amazed.
- Source: Ddu
- 636
- December 25, 2017
Market Views pharmaceutical drugs
U.S. FDA approves new diabetes drug from Merck and Pfizer

A new drug developed by Merck & Co and Pfizer Inc won U.S. approval on Wednesday to treat type II diabetes, the Food and Drug Administration(FDA) said, adding another competitor to a growing class of treatments.
- Source: Reuters
- 682
- December 25, 2017
ertugliflozin Merk New Approvals Pfizer
The Holiday Season Can Bring New Obstacles For Addicts, Here’s How to Help

If left unidentified, a compulsive behavior can turn into a new addiction. Even if your substance recovery is strong, you can’t ignore the fact that other addictions can come forward.
- Source: msn
- 368
- December 25, 2017
Holiday Season Researches
Researchers 3D-Print Patch That Heal Heart After Heart Attack

Heart disease kills more than 360,000 people a year, in the US alone. During a heart attack, a person loses blood flow to the heart muscle, causing cells to die. The heart muscle cells can't be replaced, so the body forms scar tissue, which puts the person at risk for compromised heart function and future heart failure.
- Source: mindsofmalady
- 552
- December 22, 2017
heart attacks Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.